| Accession Number: | 0001209191-21-049420 |
| Date: | 2021-08-02 |
| Issuer: | NURIX THERAPEUTICS, INC. (NRIX) |
| Original Submission Date: |
HANSEN GWENN
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO, CA 94158
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-08-02 | M | 400 | a | $7.26 | 14,204 | direct | ||
| COMMON STOCK | 2021-08-02 | S | 400 | d | $31.21 | 13,804 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 7.26 | 2021-08-02 | deemed execution date | M | 400 (d) | 2030-02-26 | common stock 400 | $7.26 | 71,466 | direct |
| ID | footnote |
|---|---|
| f1 | this transaction was effected pursuant to a rule 10b5-1 trading plan previously adopted by the reporting person. |
| f2 | the stock option vests as to 1/48 of the total shares monthly beginning february 18, 2020 until the option is fully vested on january 18, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. the option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase. |
